March 13, 2026
TOPLINE: A single peer-led Brief Alcohol Screening and Intervention for College Students (BASICS) session resulted in a reduction in weekly alcohol consumption by more than three […]
March 12, 2026
The use of stimulants , typically in conjunction with opioids, has risen steadily since at least 2015, but several new reports indicate a potential shift away […]
March 12, 2026
Prescribing of benzodiazepines to US adults declined between 2018 and 2022, especially among those aged 56 years or older, new research revealed. Researchers found a decrease […]
March 11, 2026
A web-based tool that personalizes antidepressant selection based on clinical characteristics and patient preferences was associated with a significant decrease in early treatment discontinuation in adults […]
March 10, 2026
At the 24th edition of the L’Encéphale Congress, a psychiatry conference held in Paris, France, speakers highlighted the diagnostic and therapeutic challenges of conditions that lie […]
March 9, 2026
TOPLINE: Major depressive disorder (MDD) was prevalent among 32% of all individuals with cannabis use disorder (CUD) in a new meta-analysis, and CUD was prevalent among […]
March 6, 2026
TOPLINE: Mindfulness-based auditory hallucination management (MBAHM) added to routine care for 8 weeks was associated with a greater reduction in auditory hallucinations, anxiety, and depression, as […]
March 6, 2026
TOPLINE: Childbirth-related posttraumatic stress symptoms (CB-PTSS) affected up to 13% of mothers and 1.3% of co-parents. Subjective birth perception was a key risk factor for CB-PTSS […]
March 3, 2026
A group of leading autism researchers has struck an independent advisory committee to respond to non-evidence-based claims about the condition by a long-standing federal panel. The […]